Aemetis to Review Third Quarter 2024 Financial Results on November 12, 2024

Stock Information for Akebia Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Akebia Therapeutics Inc.

Aemetis Registrations Approved by the IRS for 45Z Production Tax Credits
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q3 2024
Aemetis Biogas Starts Production From Tenth Dairy Digester With Additional Digesters in Final Stages of Commissioning and Construction
Aemetis India Completes $103 Million of Biodiesel Deliveries to OMCs in 2024 and Receives Initial $58 Million Allocation for the 2025 Marketing Year
Aemetis Reports Revenues of $81 Million for the Third Quarter 2024
Aemetis Announces Support for Updated Low Carbon Fuel Standard and Encourages CARB Adoption on November 8th
Aemetis Named 7th Hottest Company in the Bioeconomy at Advanced Bioeconomy Leadership Conference
Aemetis Biogas Completes Initial Construction Phase of Multi-Dairy Digester

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.